Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 28. März 2026
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2182  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 43631  
   
Hidden Challenges: A Cross-Sectional Study on Prevalence and Determinants of Sexual Dysfunction in Men and Women with Multiple Sclerosis.
Medicina (Kaunas)
Latella D, Giambò FM, La Rosa G, Bonanno L, Calabrò RS.
PMID: 41901603 [PubMed - indexed for MEDLINE]


Early Prognostic Factors in Multiple Sclerosis: Clinical and Therapeutic Implications.
Medicina (Kaunas)
Maciejowska-Szyd, Puz P.
PMID: 41901557 [PubMed - indexed for MEDLINE]


Clinical, Cognitive and Demographic Determinants of Work Participation in Multiple Sclerosis: A Multicenter Cross-Sectional Study.
Medicina (Kaunas)
Stavrogianni K, Kitsos DK, Dimitriadou EM, Akrivaki A, Chasiotis AK, Vlotinou P, Paraskevas GP, Tsivgoulis G, Bakalidou D, Tsamis K, Peschos D, Giannopapas V, Tzartos JS, Giannopoulos S.
PMID: 41901537 [PubMed - indexed for MEDLINE]


Central and Peripheral Characterization of Key Kynurenine Pathway Metabolites in Mexican Patients with Multiple Sclerosis: An Exploratory Study.
Pharmaceuticals (Basel)
Acosta Mendez PA, Ordoñez G, Meza-Sosa KF, Blanco Ayala T, Ramirez Ortega D, Pérez de la Cruz G, González Esquivel DF, Corona T, Flores Rivera J, Rivas V, Carrillo Mora P, Aláez-Verson C, Sathyasaikumar KV, Gomez-Manzo S, Salazar A, Pineda B, Pérez de la Cruz V.
PMID: 41901358 [PubMed]


Clinical Prediction of Functional Decline in Multiple Sclerosis Using Volumetry-Based Synthetic Brain Networks.
Life (Basel)
Ciubotaru A, Ma, Schreiner TG, Filip C, Covali R, Riscanu L, Bilcu RV, Cucu LE, Socolov-Mihaita SA, L, Crivoi F, Vamanu A, Martu I, Dima-Cozma LC, Cozma RS, Bitere-Popa OR.
PMID: 41900977 [PubMed]


A Randomized, Open, Single-Administration, Cross-Over Study to Investigate the Acceptability, Swallowability, Palatability, and Preference of Different Oral Placebo Formulations in Patients with Multiple Sclerosis.
Pharmaceutics
Bosse HM, Karosaite K, Kloft C, Schütte M, Pawlitzki M, Albrecht P, Chauhan S, Gallou I, Chabaud S, Sawai T, Tumuluri H, Wargenau M, Spitzhorn LS, Klingmann V.
PMID: 41900839 [PubMed]


Exercise Training and Biomarkers of Neuroaxonal Injury in Multiple Sclerosis: Narrative Review.
Int J Environ Res Public Health
Martin TB, Dubose NG, Motl RW.
PMID: 41899757 [PubMed - indexed for MEDLINE]


Circulating Proinflammatory Cytokines and Soluble Cytokine Receptors as Diagnostic Biomarkers in Multiple Sclerosis.
J Clin Med
Bano S, Choudhry N, Numan A, Gondal AJ, Yasmin N.
PMID: 41899320 [PubMed]


Immunogenicity of Hepatitis B Virus Vaccination in Relapsing-Remitting Multiple Sclerosis Patients Under Immunocompromising Treatment.
Int J Mol Sci
Cruces-Párraga J, Muñoz-Jurado A, Escribano BM, Martín-Hersog FA, Triguero-Ortiz C, Carmona-Medialdea C, Túnez I, Caballero-Villarraso J, Agüera-Morales E.
PMID: 41898661 [PubMed - indexed for MEDLINE]


Correlations Between OCTA Parameters and Clinical Changes in Patients Newly Diagnosed with Multiple Sclerosis.
Diagnostics (Basel)
Enache II, Tiu VE, Anghel CA, Popa Cherecheanu A, Bostan M, Chua J, Li C, Cheong JW, Schmetterer L, Tiu C.
PMID: 41897561 [PubMed]


Needs, experiences, and knowledge of people with primary progressive multiple sclerosis: a scoping review.
Neurol Sci
Giordano A, Di Domenico G, Hickstein J, Rasev L, Robles-Sanchez MA, Galán I, Murillo ERM, Novotna K, Wiemann M, Schnakenberg R, Hynes SM, Solari A, Heesen C, Rahn AC.
PMID: 41896398 [PubMed - in process]


Systematic Review of Monoclonal Antibody Therapies in Relapsing Multiple Sclerosis: Comparator-Stratified Analysis of Relapse and Disability Outcomes.
Med Sci (Basel)
Ciubotaru A, Grosu C, Ma, Constantinescu V, Alexa D, Covali R, Riscanu L, Bilcu RV, Cucu LE, Ga, Socolov-Mihaita SA, L, Crivoi F, Vamanu A, Patrascu A, Ignat EB.
PMID: 41892831 [PubMed - indexed for MEDLINE]


Obesity, Nutrition and the Multiple Sclerosis Risk in Adolescents.
Brain Sci
Giovengo M, Rosa M, Mandato C.
PMID: 41892626 [PubMed]


Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants.
Ann Clin Transl Neurol
Gold R, Selmaj KW, Berkovich R, Cohen JA, Comi G, Havrdová EK, Sheffield JK, Desai H, Cheng CY, Riolo JV, Thorpe A, DeBoer E, Cree BAC.
PMID: 41891136 [PubMed - as supplied by publisher]


Combining magnetic resonance imaging and evoked potentials enhances machine learning prediction of multiple sclerosis disability worsening.
Front Immunol
Aerts S, Werthen-Brabants L, Khan H, Giraldo DL, De Brouwer E, Geys L, Popescu V, Sijbers J, Woodruff HC, Dhaene T, Deschrijver D, Van Wijmeersch B, Lambin P, Peeters LM.
PMID: 41890713 [PubMed - indexed for MEDLINE]


Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis - A meta-analysis.
Mult Scler J Exp Transl Clin
Elkhooly M, Jacob R, Rempe T.
PMID: 41890616 [PubMed]


Interplay between genetic and environmental risk factors in multiple sclerosis: what have we learned?
Brain
Jacobs BM, Vandebergh M, Maltby VE, Dobson R, Kreft KL.
PMID: 41889330 [PubMed - as supplied by publisher]


Autonomic reactivity to stress in multiple sclerosis: A meta-analytic review.
Mult Scler Relat Disord
Ranfaing S, Degraeve B, Lenne B, Sequeira H.
PMID: 41886880 [PubMed - as supplied by publisher]


Insights from a trial of narrowband UVB for early multiple sclerosis.
Photochem Photobiol Sci
Hart PH, Trend S, Kermode AG, Leffler J, MacMahon J.
PMID: 41886257 [PubMed - as supplied by publisher]


From Demyelination to Intervention: Natural Compounds as Emerging Therapeutic Targets in Multiple Sclerosis Neuroinflammation.
J Immunol Res
Long Z, Yang Q, Wu Y, Wan L, Zeng L, Sun L.
PMID: 41885581 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 43631    Seite 1 von 2182  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1